These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 28859257)

  • 1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
    Navarro D; San-Juan R; Manuel O; Giménez E; Fernández-Ruiz M; Hirsch HH; Grossi PA; Aguado JM;
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28859257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
    Razonable RR; Humar A
    Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of cytomegalovirus viral load in solid organ transplant recipients.
    Dioverti MV; Razonable RR
    Curr Opin Infect Dis; 2015 Aug; 28(4):317-22. PubMed ID: 26098497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.
    Razonable RR; Hayden RT
    Clin Microbiol Rev; 2013 Oct; 26(4):703-27. PubMed ID: 24092851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients.
    Gardiner BJ; Chow JK; Brilleman SL; Peleg AY; Snydman DR
    Transpl Infect Dis; 2019 Dec; 21(6):e13189. PubMed ID: 31581352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.
    Martín-Gandul C; Pérez-Romero P; Sánchez M; Bernal G; Suárez G; Sobrino M; Merino L; Cisneros JM; Cordero E;
    J Clin Virol; 2013 Jan; 56(1):13-8. PubMed ID: 23131346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
    Singh N; Winston DJ; Razonable RR; Lyon GM; Silveira FP; Wagener MM; Stevens-Ayers T; Edmison B; Boeckh M; Limaye AP
    JAMA; 2020 Apr; 323(14):1378-1387. PubMed ID: 32286644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation.
    Grossi PA; Kamar N; Saliba F; Baldanti F; Aguado JM; Gottlieb J; Banas B; Potena L
    Transpl Int; 2022; 35():10332. PubMed ID: 35812158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients.
    Khoury JA; Storch GA; Bohl DL; Schuessler RM; Torrence SM; Lockwood M; Gaudreault-Keener M; Koch MJ; Miller BW; Hardinger KL; Schnitzler MA; Brennan DC
    Am J Transplant; 2006 Sep; 6(9):2134-43. PubMed ID: 16780548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J; Rotjanapan P; Watcharananan SP
    Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.
    Ekenberg C; da Cunha-Bang C; Lodding IP; Sørensen SS; Sengeløv H; Perch M; Rasmussen A; Gustafsson F; Wareham NE; Kirkby N; Kjaer J; Helleberg M; Reekie J; Lundgren JD
    Transpl Infect Dis; 2020 Apr; 22(2):e13252. PubMed ID: 31997565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacist-driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients.
    Wang N; Athans V; Neuner E; Bollinger J; Spinner M; Brizendine K
    Transpl Infect Dis; 2018 Dec; 20(6):e12991. PubMed ID: 30184302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International survey of cytomegalovirus management in solid organ transplantation after the publication of consensus guidelines.
    Le Page AK; Jager MM; Kotton CN; Simoons-Smit A; Rawlinson WD
    Transplantation; 2013 Jun; 95(12):1455-60. PubMed ID: 23640298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
    Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
    J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ; Razonable RR
    Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of real-time PCR and pp65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone marrow transplants.
    Marchetti S; Santangelo R; Manzara S; D'onghia S; Fadda G; Cattani P
    New Microbiol; 2011 Apr; 34(2):157-64. PubMed ID: 21617827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.
    Panagou E; Zakout G; Keshani J; Smith C; Irish D; Mackinnon S; Kottaridis P; Fielding A; Griffiths PD
    Transpl Infect Dis; 2016 Jun; 18(3):405-14. PubMed ID: 27061703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.